Skip to main content

Market Overview

AVIVAGEN to Present at The LD 500 Virtual Conference

Share:

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Avivagen: (TSXV:VIV)(OTCQB:VIVXF), a life sciences company with a natural, approved and patented alternative to antibiotics, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:40 PM PST/9:40 AM EST. Kym Anthony, Chief Executive Officer will be presenting to a live audience.

Register here: https://ld-micro-conference.events.issuerdirect.com/

"We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space." stated Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View AVIVAGEN'S profile here: http://www.Id/micro.com/profile/VIV

Profiles powered by LD Micro - News Compliments of Accesswire

About AVIVAGEN:

We are a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

Name: Drew Basek
Phone: 416-540-0733
Address:100 Sussex Drive
Ottawa, Ontario
Canada K1A 0R6
Email: d.basek@avivagen.com

SOURCE: Avivagen.com via LD Micro

View source version on accesswire.com:
https://www.accesswire.com/601582/AVIVAGEN-to-Present-at-The-LD-500-Virtual-Conference

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com